Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Observer-Blind, Active-Controlled, Clinical Trial to Assess the Immunogenicity of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults

NCT06354998 is registered in ClinicalTrials.gov with ModernaTX, Inc. as lead sponsor.

NCT NCT06354998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06354998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Observer-Blind, Active-Controlled, Clinical Trial to Assess the Immunogenicity of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults
Lead sponsor
ModernaTX, Inc.
Phase
Phase 3
Overall status
Completed
Start date
April 8, 2024
Completion date
May 10, 2024
Enrollment
217 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2